Literature DB >> 6235909

In vitro elicitation of cytotoxic response against a nonimmunogenic murine tumor by allosensitization.

B Leshem, B Gotsman, E Kedar.   

Abstract

The murine lymphoma (thymoma) PIR-2 of C57BL/6 origin, primarily induced in our laboratory by fractionated X-ray irradiation, has been shown to be nonimmunogenic by its failure to immunize syngeneic mice in vivo or to evoke a cytotoxic response in primary mixed lymphocyte-tumor cell cultures (MLTC) in vitro. We were able, however, to demonstrate the existence of anti-PIR-2 cytotoxic cells among allogeneic-primed C57BL/6 responding lymphocytes using the technique of limiting dilution cultures (LDC). The frequency of anti-PIR-2 cytotoxic cells among C57BL/6 lymphocytes sensitized against BALB/c splenocytes in mixed leukocyte culture (MLC) was 1/20 to 1/40, and the cytotoxic activity of positive LDC wells against PIR-2 reached 60% as determined by a 4-h 51Cr-release assay. The frequency of anti-PIR-2 cytotoxic cells could be increased two- to 10-fold (up to 1/4) by removing nylon-wool-adherent cells from the primed cell population and/or by enriching the primed lymphoblast population on a Percoll density gradient. Anti-PIR-2 cytotoxic cells were found to be Thy1+; Lyt1-2+ cells. Clones isolated from the LDC wells manifested strong cytotoxic activity toward PIR-2 cells and the stimulating BALB/c splenocytes but not against other H-2b tumor lines or C57BL/6 splenocytes. We suggest that the procedure of allostimulation in MLC-LDC is an effective in vitro means of generating highly reactive cytotoxic cells against poorly immunogenic neoplasms.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6235909     DOI: 10.1007/bf00200047

Source DB:  PubMed          Journal:  Cancer Immunol Immunother        ISSN: 0340-7004            Impact factor:   6.968


  26 in total

1.  Generation of cytotoxic T lymphocytes to autologous human leukaemia cells by sensitisation to pooled allogeneic normal cells.

Authors:  J M Zarling; H I Robins; P C Raich; F H Bach; M L Bach
Journal:  Nature       Date:  1978-07-20       Impact factor: 49.962

2.  Antibody-induced redistribution of normal and tumor associated surface antigens.

Authors:  E Yefenof; G Klein
Journal:  Exp Cell Res       Date:  1974-10       Impact factor: 3.905

3.  T cell growth factor: parameters of production and a quantitative microassay for activity.

Authors:  S Gillis; M M Ferm; W Ou; K A Smith
Journal:  J Immunol       Date:  1978-06       Impact factor: 5.422

4.  Lysis of syngeneic solid tumor cells by alloantigen stimulated mouse T and non-T cells.

Authors:  P A Paciucci; S Macphail; J M Zarling; F H Bach
Journal:  J Immunol       Date:  1980-01       Impact factor: 5.422

5.  H-2 antigen expression: Loss in vitro, restoration in vivo, and correlation with cell-mediated cytotoxicity in a mouse lymphoma cell line.

Authors:  O J Finn; M Lieberman; H S Kaplan
Journal:  Immunogenetics       Date:  1978-12       Impact factor: 2.846

6.  Lysis of fresh human solid tumor cells by autologous lymphocytes activated in vitro by allosensitization.

Authors:  A Mazumder; E A Grimm; S A Rosenberg
Journal:  Cancer Immunol Immunother       Date:  1983       Impact factor: 6.968

7.  Lysis of autologous human melanoma cells by in vitro allosensitized peripheral blood lymphocytes.

Authors:  G Fossati; A Balsari; D Taramelli; M L Sensi; G Pellegris; M Nava; G Parmiani
Journal:  Cancer Immunol Immunother       Date:  1982       Impact factor: 6.968

8.  In vitro studies on the cell-mediated immune response to human brain tumors. I. Requirement for third-party stimulator lymphocytes in the induction of cell-mediated cytotoxic responses to allogeneic cultured gliomas.

Authors:  M K Gately; M Glaser; S J Dick; R W Mettetal; P L Kornblith
Journal:  J Natl Cancer Inst       Date:  1982-12       Impact factor: 13.506

9.  Autologous leukemia-specific T-cell-mediated lymphocytotoxicity in patients with acute myelogenous leukemia.

Authors:  S K Lee; R T Oliver
Journal:  J Exp Med       Date:  1978-03-01       Impact factor: 14.307

10.  Lysis of tumor biopsy cells by autologous T lymphocytes activated in mixed cultures and propagated with T cell growth factor.

Authors:  F Vánky; T Gorsky; Y Gorsky; M G Masucci; E Klein
Journal:  J Exp Med       Date:  1982-01-01       Impact factor: 14.307

View more
  9 in total

1.  Chemo-immunotherapy of murine tumors using interleukin-2 (IL-2) and cyclophosphamide. IL-2 can facilitate or inhibit tumor growth depending on the sequence of treatment and the tumor type.

Authors:  E Kedar; R Ben-Aziz; E Epstein; B Leshem
Journal:  Cancer Immunol Immunother       Date:  1989       Impact factor: 6.968

Review 2.  The role of contrasuppression in tumor regression.

Authors:  P M Flood; A Friedman; J Freedman; B Horvat; P Reuter; W Ptak
Journal:  Immunol Res       Date:  1988       Impact factor: 2.829

3.  Auto-tumor lysis by blood lymphocytes in vitro. Strongly activated lymphocytes lack selectivity.

Authors:  F Vánky; E Klein
Journal:  Cancer Immunol Immunother       Date:  1989       Impact factor: 6.968

4.  Mouse lymphoblasts lose their immunogenicity and susceptibility to specific cytotoxic T lymphocyte lysis during maintenance in culture.

Authors:  B Leshem; D Brass
Journal:  Immunology       Date:  1998-11       Impact factor: 7.397

5.  Adoptive immunotherapy of a BALB/c lymphoma by syngeneic anti-DBA/2 immune lymphoid cells: characterization of the effector population and evidence for the role of the host's non-T cells.

Authors:  M P Colombo; M Parenza; G Parmiani
Journal:  Cancer Immunol Immunother       Date:  1985       Impact factor: 6.968

6.  Analysis of the cellular immune response to and adoptive immunotherapy of a BALB/c lymphoma that cross-reacts with normal DBA/2 cells.

Authors:  M Sensi; L Grazioli; G Parmiani
Journal:  Cancer Immunol Immunother       Date:  1986       Impact factor: 6.968

7.  Clinical adoptive chemoimmunotherapy with allogeneic alloactivated HLA-haploidentical lymphocytes: controlled induction of graft-versus-host-reactions.

Authors:  P C Kohler; J A Hank; D Z Minkoff; P M Sondel
Journal:  Cancer Immunol Immunother       Date:  1988       Impact factor: 6.968

8.  Alloantigen persistence in induction and maintenance of transplantation tolerance.

Authors:  S Morecki; B Leshem; A Eid; S Slavin
Journal:  J Exp Med       Date:  1987-06-01       Impact factor: 14.307

9.  Cytotoxic T lymphocytes reactive against a syngeneic murine tumor and their specific suppressor T cells are both elicited by in vitro allosensitization.

Authors:  B Leshem; E Kedar
Journal:  J Exp Med       Date:  1990-04-01       Impact factor: 14.307

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.